News & Updates

Show Multimedia Only

ThuFLEP noninferior to HoLEP in terms of functional outcomes in BPO

25 Mar 2026 by

Thulium fibre laser enucleation of the prostate (ThuFLEP) was noninferior to Holmium laser enucleation of the prostate (HoLEP) regarding functional outcomes over 24 months in patients with benign prostatic obstruction (BPO), according to a trial presented at EAU26.

ThuFLEP noninferior to HoLEP in terms of functional outcomes in BPO

25 Mar 2026

Severe infections added to list of obesity-related comorbidities

24 Mar 2026 by

Adults with obesity are at increased risk of infection-related hospitalizations and mortality, with a 10th of infection-related deaths estimated to be attributable to obesity, according to a study.

Severe infections added to list of obesity-related comorbidities

24 Mar 2026

AUA 2025 guidelines help predict urothelial neoplasm risk in MH patients

24 Mar 2026

The 2025 guidelines set by the American Urological Association (AUA) improve stratification of patients with microscopic hematuria (MH) into risk groups for urothelial cancer, but not renal cortical neoplasms of any kind, according to a study.

AUA 2025 guidelines help predict urothelial neoplasm risk in MH patients

24 Mar 2026

Enzalutamide improves outcomes in prostate cancer with hrBCR

24 Mar 2026 by

Treatment with enzalutamide monotherapy demonstrates numerically higher overall survival (OS) in prostate cancer patients with high-risk biochemical recurrence (hrBCR) when compared with leuprolide alone, but the difference is not statistically significant, as shown by the results of the EMBARK study.

Enzalutamide improves outcomes in prostate cancer with hrBCR

24 Mar 2026

Upadacitinib improves CD, UC in patients with prior tofacitinib failure

24 Mar 2026

Treatment with upadacitinib induces clinical remission and endoscopic improvement in most patients with severe, refractory Crohn’s disease (CD) or ulcerative colitis (UC) with prior tofacitinib failure, regardless of previous response to tofacitinib, a study has shown.

Upadacitinib improves CD, UC in patients with prior tofacitinib failure

24 Mar 2026

TXA POISEd for use in urologic surgery

24 Mar 2026 by

The POISE-3 trial supports the use of tranexamic acid (TXA) in patients undergoing urologic surgery at increased risk of bleeding.

TXA POISEd for use in urologic surgery

24 Mar 2026

A Coffee Talk on MAC 16: Brewing Ideas in Endocrinology

24 Mar 2026 by

Dr Elliyyin Katiman (Chair, MAC 16):
“Good morning! Planning the 16th Malaysian Endocrine and Metabolic Society Annual Congress has been quite the journey. But seeing everything come together under the theme ‘Synergy in Endocrinology’ makes it incredibly rewarding.”

A Coffee Talk on MAC 16: Brewing Ideas in Endocrinology

24 Mar 2026

Acid suppressant use tied to risk of ischaemic events in stroke patients on clopidogrel

24 Mar 2026

Acid suppressants such as potassium-competitive acid blockers (P-CABs) and proton pump inhibitors (PPIs), when used concomitantly with clopidogrel, carry an increased risk of ischaemic events in stroke patients, according to a retrospective cohort study.

Acid suppressant use tied to risk of ischaemic events in stroke patients on clopidogrel

24 Mar 2026

Safeguarding Hajj pilgrims against invasive meningococcal disease

24 Mar 2026 by

Invasive meningococcal disease (IMD) persists as a significant health risk for Hajj pilgrims due to its easy transmission in the crowded settings of Umrah.

Safeguarding Hajj pilgrims against invasive meningococcal disease

24 Mar 2026

MyNuCLEaR advancing nuclear medicine for better patient outcomes

24 Mar 2026 by

MyNuCLEaR, a nationwide collaborative initiative, serves as a comprehensive resource for healthcare professionals (HCPs) to explore nuclear medicine and innovative therapies like theranostics with the aim of improving patient care.

MyNuCLEaR advancing nuclear medicine for better patient outcomes

24 Mar 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

ThuFLEP noninferior to HoLEP in terms of functional outcomes in BPO

ThuFLEP noninferior to HoLEP in terms of functional outcomes in BPO

Severe infections added to list of obesity-related comorbidities

Severe infections added to list of obesity-related comorbidities

AUA 2025 guidelines help predict urothelial neoplasm risk in MH patients

AUA 2025 guidelines help predict urothelial neoplasm risk in MH patients

Enzalutamide improves outcomes in prostate cancer with hrBCR

Enzalutamide improves outcomes in prostate cancer with hrBCR

Upadacitinib improves CD, UC in patients with prior tofacitinib failure

Upadacitinib improves CD, UC in patients with prior tofacitinib failure

TXA POISEd for use in urologic surgery

TXA POISEd for use in urologic surgery

A Coffee Talk on MAC 16: Brewing Ideas in Endocrinology

A Coffee Talk on MAC 16: Brewing Ideas in Endocrinology

Acid suppressant use tied to risk of ischaemic events in stroke patients on clopidogrel

Acid suppressant use tied to risk of ischaemic events in stroke patients on clopidogrel

Safeguarding Hajj pilgrims against invasive meningococcal disease

Safeguarding Hajj pilgrims against invasive meningococcal disease

MyNuCLEaR advancing nuclear medicine for better patient outcomes

MyNuCLEaR advancing nuclear medicine for better patient outcomes